This is a specific type of osteosarcoma, a bone cancer. It starts near the outer edge of the bone (the cortex) and the outer layer of bone tissue (the periosteum). It's generally considered less aggressive than other forms of osteosarcoma.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Juxtacortical osteosarcoma, more often called parosteal osteosarcoma, is a rare bone cancer that grows on the outer surface of a bone rather than inside it. It is usually low-grade, meaning its cells look and behave less aggressively than those of the more common form of osteosarcoma. It grows slowly, often over months or years, and is less likely to spread. The typical sign is a hard lump that has been present for a long time and is often painless. Most of these tumors grow on the back of the thigh bone just above the knee, where a growing mass can make it harder to bend or straighten the leg. The upper shin bone and upper arm bone are the next most common sites. It accounts for about 4 in 100 osteosarcomas and, unlike the usual form that mainly affects teenagers, it most often appears in people in their 20s and 30s, slightly more often in women. The word juxtacortical is sometimes used more broadly for any osteosarcoma on the bone surface. Two related types, periosteal and high-grade surface osteosarcoma, behave and are treated differently, so it matters which one a person actually has.
The cause of parosteal osteosarcoma is not known. The tumor cells usually carry extra copies of two genes, MDM2 and CDK4, which help drive cell growth. This change is found in the tumor itself and is useful for diagnosis, but it does not explain why the tumor started. Known risk factors for osteosarcoma in general include earlier radiation treatment, Paget's disease of bone and some inherited cancer syndromes such as Li-Fraumeni syndrome. How much these apply to this particular low-grade type is unclear, and most people who develop it have none of them. People sometimes first notice the lump after a knock or fall, but an injury is not thought to cause the tumor.
An X-ray is usually the first test. It typically shows a dense, bony mass attached to the outside of the bone by a broad base, sometimes wrapping around it. CT and MRI scans show the tumor's size, whether it has grown into the marrow cavity in the center of the bone (MRI is best for this) and how it relates to nearby muscles, nerves and blood vessels. Areas that look less dense within the tumor may sometimes suggest a more aggressive, high-grade portion. This tumor is easy to mistake for a noncancerous bone growth, such as an osteochondroma (a common benign bony bump) or myositis ossificans (bone that forms in muscle after an injury). Under the microscope its cells can also look deceptively bland. A biopsy, in which a sample of the tumor is removed and examined, is what confirms the diagnosis, and testing for the extra MDM2 and CDK4 gene copies helps separate it from benign lookalikes. The biopsy should be planned and performed at a specialist bone sarcoma center, ideally by or with the surgical team that will do the main operation. The biopsy path is chosen so it can be removed during that operation, because a poorly planned biopsy can make limb-sparing surgery or cure harder to achieve.
Surgery is the main treatment. The goal is to remove the whole tumor with a margin of healthy tissue around it, because tumors removed with close or incomplete margins are more likely to come back. For the usual low-grade form, surgery alone is the standard approach, and chemotherapy and radiation are generally not needed. Most people can have limb-sparing surgery. Depending on how much bone is removed, the gap may be rebuilt with a bone graft (often donor bone held with plates or screws), a metal implant that replaces the end of the bone and part of the knee, or newer custom-made implants. Removing only part of the bone's width preserves more of the person's own bone, but in one long-term study it was linked to more recurrences, so the extent of surgery is a balance between function and cancer control. Amputation is now uncommon but may still be the safest choice in some situations. Some tumors contain high-grade areas, either found when the removed tumor is examined or developing in a recurrence. These dedifferentiated tumors behave more like conventional osteosarcoma, and chemotherapy may be considered, although evidence on how much it helps for this situation is limited. Because the condition is rare, care is best planned by a multidisciplinary bone sarcoma team.
The outlook for low-grade parosteal osteosarcoma treated with complete surgery is generally good. In one large series followed for up to 21 years, about 95 in 100 people were alive at 5 years and about 88 in 100 at 15 years. Tumors with high-grade areas carry a less favorable outlook. Recovery depends mainly on how much bone was removed and how it was rebuilt. Reconstructions can need further surgery over the years if a graft or implant fails, sometimes more than 10 years after the first operation. This tumor can return late. In the same series, a little over 1 in 5 people had the tumor come back at the original site, and about half of those recurrences appeared more than 10 years after treatment. About 1 in 8 developed spread elsewhere in the body, and nearly half of these cases were found more than 10 years after treatment. A smaller number, about 1 in 14, had the tumor return in a more aggressive, high-grade form. For this reason, follow-up is long-term. For low-grade bone sarcomas, guidelines suggest checkups every 4 to 6 months for the first 2 years and then yearly, typically with an examination, an X-ray of the treated area and a chest X-ray. There is no agreed point at which follow-up can safely stop.
See a clinician about a hard lump on a bone that does not go away or keeps growing, especially near the knee, or about bone pain that persists or wakes you at night. A recent injury does not rule out a bone tumor. If imaging suggests a bone tumor, ask to be referred to a specialist bone sarcoma center before any biopsy or surgery is done. After treatment, contact your sarcoma team about a new lump or swelling at or near the treated site, new or worsening pain there, or a change in how the reconstructed limb feels or works, even many years later. Keep up with scheduled follow-up imaging even if you feel well.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Juxtacortical Osteosarcoma is like, what's helped you, or ask the community a question.